Malaysia NPRA Publishes 4th Edition of Licensing Guideline for Registered Products

On July 29, 2026, Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) published the fourth edition of the Guideline on Application of Manufacturer’s License, Import License and Wholesaler’s License for Registered Products.

The guideline sets out the requirements and procedures for applying for, renewing, and changing licenses required to manufacture, import, wholesale, or supply products registered with the Drug Control Authority (DCA).

It covers:

• Manufacturer’s, Import, and Wholesaler’s License applications
• Supporting documentation, responsible persons, and processing fees
• Applicable manufacturing, storage, and premises requirements
• License renewal requirements
• Changes requiring a new license application
• Adding products to existing Manufacturer’s and Import Licenses

For pharmaceutical companies operating in or entering Malaysia, the guideline provides a consolidated reference for managing licensing requirements associated with registered products.

Looking Beyond Licensing

The fourth edition provides a consolidated reference for license management for registered products in Malaysia, but licensing is only one part of the market-entry process. Companies must also coordinate local licensing with product registration, local representation, applicable facility and quality requirements, and ongoing post-market obligations.

This is where local regulatory support can make a practical difference. With an office in Malaysia, Cisema works directly with pharmaceutical companies on local regulatory requirements, helping them navigate licensing and market-entry requirements while coordinating these activities with their wider Asia-Pacific strategy.

If you are planning to enter the Malaysian market, expand your product portfolio, or review your existing licensing arrangements, get in touch with Cisema today to discuss your requirements.

Further Information

• Explore Cisema’s pharmaceutical consulting services.
• Learn about Cisema’s pharmaceutical regulatory affairs consulting services.

References

• Guideline on Application of Manufacturer’s License, Import License and Wholesaler’s License for Registered Products (4th Edition, July 2026)